Skip to main content
Indian drugmaker to expand API facilities

Mumbai, India-based Piramal Pharma Solutions is expanding its active pharmaceutical ingredient manufacturing capabilities in North America, the UK and Asia. The drugmaker will invest $55 million to build new plants and expand capabilities at existing sites, according to the company.

Full Story: